Cargando…
Physician uncertainty aversion impacts medical decision making for older patients with acute myeloid leukemia: results of a national survey
Elderly patients with acute myeloid leukemia can be treated with intensive chemotherapy, low-intensity therapy such as low-dose aracytine or hypomethylating agents, or best supportive care. The choice between these treatments is a function of many patient-related and disease-related factors. We inve...
Autores principales: | Bories, Pierre, Lamy, Sébastien, Simand, Célestine, Bertoli, Sarah, Delpierre, Cyrille, Malak, Sandra, Fornecker, Luc, Moreau, Stéphane, Récher, Christian, Nebout, Antoine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ferrata Storti Foundation
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269286/ https://www.ncbi.nlm.nih.gov/pubmed/30006448 http://dx.doi.org/10.3324/haematol.2018.192468 |
Ejemplares similares
-
Impact of TP53 mutations in acute myeloid leukemia patients treated with azacitidine
por: Bories, Pierre, et al.
Publicado: (2020) -
Are social inequalities in acute myeloid leukemia survival explained by differences in treatment utilization? Results from a French longitudinal observational study among older patients
por: Berger, Eloïse, et al.
Publicado: (2019) -
Cross-sectional survey: risk-averse French GPs use more rapid-antigen diagnostic tests in tonsillitis in children
por: Michel-Lepage, Audrey, et al.
Publicado: (2013) -
Retrospective, real‐life study of venetoclax plus azacitidine or low‐dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy
por: Laloi, Louise, et al.
Publicado: (2022) -
Ambiguity and Conflict Aversion When Uncertainty Is in the Outcomes
por: Smithson, Michael, et al.
Publicado: (2019)